Britain prepares for possible influenza pandemic

The UK Health Security Agency (UKHSA) has announced the completion of a contract for over five million doses of the human H5 influenza vaccine. This step is part of preparations for a potential influenza pandemic. The vaccine is to be manufactured by CSL Seqirus in the United Kingdom and will only be used if there is a spread of the virus among humans. Currently, there is no evidence of such human-to-human transmission, as the agency emphasizes. This precautionary measure underscores the importance of proactive strategies in public health and the biopharmaceutical industry.